Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
DOJ
Insys $225 Million Settlement and Corporate Integrity Agreement
Last month, buried in all the other Insys news, was the news that Insys Therapeutics agreed to pay $225 million and plead guilty…
Heritage Pharmaceuticals Admits to Price Fixing, Agrees to Cooperate with…
Recently, it was announced that Heritage Pharmaceuticals, Inc., a generic pharmaceutical company, was charged with conspiring with…
Mallinckrodt in Hot Water: Tries to Reach Settlement, Gets Hit With New…
01On June 5, 2019, the United States Department of Justice (DOJ) announced that it filed a complaint under the False Claims Act…
DOJ Charges 24 Defendants in Medicare Knee Brace Scheme
Over the past few years it has been hard to avoid the radio and television ads encouraging Medicare recipients with back or knee…
Newly Created Appalachian Opioid Strike Force Charges 60 Defendants for…
As the opioid addiction epidemic rages on, various Federal government agencies continue enforcement efforts in an attempt to stem…
DOJ Criminal Division Announces Updated Guidance on Evaluating Corporate…
On April 30, 2019, the US Department of Justice (“DOJ”) Criminal Division announced the publication of an updated guidance…
Pharma Executives on Notice: Jury Convicts Insys Founder and Four Former…
On May 2, 2019, a federal jury convicted the founder and four former executives of Insys Therapeutics, Inc. (Insys) of a…
US WorldMeds Settlement and Corporate Integrity Agreement to Resolve FCA…
On April 30, 2019, US WorldMeds LLC (“USWM”) agreed to pay $17.4 million to resolve Department of Justice (“DOJ”) allegations that…
First Ever Felony Criminal Charges’ Against a Distributor and its Former…
On April 23, 2019, the Manhattan U.S. Attorney and N.Y. Division of the Drug Enforcement Administration announced the “first ever…
FTC Finds Impax-Endo “No Approved Generic” Agreement to be Anticompetitive…
On March 28, 2019, the Federal Trade Commission (“FTC”) issued an Opinion and Final Order against Impax Laboratories LLC…